Literature DB >> 21171825

CXCR4 and matrix metalloproteinase-2 are involved in mesenchymal stromal cell homing and engraftment to tumors.

Chao Song1, Gang Li.   

Abstract

BACKGROUND AIMS: Bone marrow-derived mesenchymal stromal cells (BMSC) have been shown to migrate to injury, ischemia and tumor microenvironments. The mechanisms by which mesenchymal stromal cells (MSC) migrate across endothelium and home to the target tissues are not yet fully understood.
METHODS: We used rat BMSC to investigate the molecular mechanisms involved in their tropism to tumors in vitro and in vivo.
RESULTS: BMSC were shown to migrate toward four different tumor cells in vitro, and home to both subcutaneous and lung metastatic prostate tumor models in vivo. Gene expression profiles of MSC exposed to conditioned medium (CM) of various tumor cells were compared and revealed that matrix metalloproteinase-2 (MMP-2) expression in BMSC was downregulated after 24 h exposure to tumor CM. Chemokine (C-X-C motif) Receptor 4 (CXCR4) upregulation was also found in BMSC after 24 h exposure to tumor CM. Exposure to tumor cell CM enhanced migration of BMSC toward tumor cells. Stromal Cell-Derived Factor (SDF-1) inhibitor AMD3100 and MMP-2 inhibitor partly abolished the BMSC migration toward tumor cells in vitro.
CONCLUSIONS: These results suggest that the CXCR4 and MMP-2 are involved in the multistep migration processes of BMSC tropism to tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21171825     DOI: 10.3109/14653249.2010.542457

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  19 in total

1.  Bone marrow-derived mesenchymal stem cell transplantation ameliorates oxidative stress and restores intestinal mucosal permeability in chemically induced colitis in mice.

Authors:  Tao Sun; Guang-Zhou Gao; Rong-Fu Li; Xin Li; Da-Wei Li; Shan-Shan Wu; Anthony Et Yeo; Bo Jin
Journal:  Am J Transl Res       Date:  2015-05-15       Impact factor: 4.060

Review 2.  Mesenchymal stem cells as a potent cell source for articular cartilage regeneration.

Authors:  Mohamadreza Baghaban Eslaminejad; Elham Malakooty Poor
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

3.  MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs.

Authors:  Qingguo Zhao; Carl A Gregory; Ryang Hwa Lee; Roxanne L Reger; Lizheng Qin; Bo Hai; Min Sung Park; Nara Yoon; Bret Clough; Eoin McNeill; Darwin J Prockop; Fei Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-29       Impact factor: 11.205

4.  Conditioned Medium From Azurin-Expressing Human Mesenchymal Stromal Cells Demonstrates Antitumor Activity Against Breast and Lung Cancer Cell Lines.

Authors:  Marília Silva; Gabriel Amaro Monteiro; Arsenio M Fialho; Nuno Bernardes; Cláudia Lobato da Silva
Journal:  Front Cell Dev Biol       Date:  2020-07-09

5.  Aqp1 enhances migration of bone marrow mesenchymal stem cells through regulation of FAK and β-catenin.

Authors:  Fanbiao Meng; Yunfeng Rui; Liangliang Xu; Chao Wan; Xiaohua Jiang; Gang Li
Journal:  Stem Cells Dev       Date:  2013-09-27       Impact factor: 3.272

6.  Reconstruction of orbital defects by implantation of antigen-free bovine cancellous bone scaffold combined with bone marrow mesenchymal stem cells in rats.

Authors:  Jingjing Zhao; Chunbo Yang; Chang Su; Min Yu; Xiaomin Zhang; Shuo Huang; Gang Li; Meili Yu; Xiaorong Li
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-03-22       Impact factor: 3.117

Review 7.  The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression.

Authors:  J M Houthuijzen; L G M Daenen; J M L Roodhart; E E Voest
Journal:  Br J Cancer       Date:  2012-05-17       Impact factor: 7.640

Review 8.  [Progress on utilizing mesenchymal stem cells as cellular delivery system for targeting delivery of as drug/gene for anti-tumor therapy].

Authors:  Ai Li; Tianyuan Zhang; Jianqing Gao
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-05-25

9.  Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts.

Authors:  Simone Pacioni; Quintino Giorgio D'Alessandris; Stefano Giannetti; Liliana Morgante; Ivana De Pascalis; Valentina Coccè; Arianna Bonomi; Luisa Pascucci; Giulio Alessandri; Augusto Pessina; Maria Laura Falchetti; Roberto Pallini
Journal:  Stem Cell Res Ther       Date:  2015-10-06       Impact factor: 6.832

Review 10.  Encapsulated stem cells for cancer therapy.

Authors:  Khalid Shah
Journal:  Biomatter       Date:  2013-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.